Yep. Assuming you read the recent announcements, analysts are predicting a requirement for cap raises to 2020. So nothing new to holders.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025